The U.S. Government Just Plowed $2 Billion Into 9 Quantum Computing Companies: Here's the Best of the Bunch
The U.S. Department of Commerce said it will invest $2 billion under the CHIPS and Science Act in nine quantum computing firms, issuing letters of intent and taking minority equity stakes, according to the department. IBM will get $1 billion for a quantum foundry subsidiary, Anderon, and GlobalFoundries will receive $375 million. The others get up to $100 million each, the article says.

Direct CHIPS Act funding to IBM’s quantum foundry subsidiary reduces near-term capital risk but limits upside linkage to commercial quantum AI due to subsidiary structure.
Commerce will invest $1B into IBM’s quantum foundry subsidiary Anderon, giving the government a minority equity stake and funding manufacturing infrastructure.
Likely modest positive bias versus broader quantum peers; magnitude may be capped by indirect exposure through Anderon.
Background
The Commerce Department announced letters of intent to invest $2B across nine quantum computing companies under the CHIPS and Science Act, taking minority equity stakes in return.
Why it matters
The key tradable element is the allocation of up to $100M to public quantum pure-plays (D-Wave, Rigetti, Infleqtion) and $1B/$375M to IBM and GlobalFoundries for quantum foundry infrastructure, which the article frames as reducing near-term capital risk.
Market relevance
Direct CHIPS Act funding is a concrete catalyst for public quantum names, likely supporting near-term momentum but with execution risk still high.
Market effects
CHIPS Act-style equity stakes and foundry funding may compress perceived capital risk across quantum manufacturing and supply-chain narratives.
U.S.-centric manufacturing push could favor domestic semiconductor/quantum infrastructure sentiment.
Signals sustained U.S. government support for quantum commercialization, potentially influencing global competitive positioning and partnerships.
Alternative perspectives
Funding de-risks capital needs, but it doesn’t guarantee technical milestones; early-stage quantum names may still trade on hype versus measurable progress.
IBM’s exposure is via a subsidiary (Anderon), so investors may overestimate direct earnings leverage; also, the article notes some recipients are still private, limiting immediate public comparability.
Key entities
- government agencyDepartment of Commerce
Announced letters of intent for $2B investments across nine quantum computing companies under the CHIPS and Science Act.
- subsidiaryAnderon
IBM quantum foundry subsidiary created to receive $1B in Commerce funding.
- facilityGlobalFoundries quantum foundry
Complementary foundry initiative funded with $375M to support multiple quantum modalities.


